Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting
benefit of adjuvant docetaxel in patients with oestrogen
receptor positive breast cancer

- Sonnenblick, Amir; Francis, Prudence A.; Lluch, Ana; Gnant, Michael; Goldhirsch, Aron; Di Leo, Angelo; Barnadas, Agusti; Cortes-Funes, Hernan; Piccart, Martine; Crown, John; Azim Jr, Hatem A.; de Azambuja, Evandro; Nordenskjold, Bo; Gutierez, Jorge; Quinaux, Emmanuel; Mastropasqua, Mauro G.; Ameye, Lieveke; Anderson, Michael